Quantitative assessment of the influence of tumor necrosis factor alpha polymorphism with gastritis and gastric cancer risk

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 1495-1502

  Li, Ming ^a   Wang, Yinping ^b   Gu, Yahong ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gastric cancer; Gastritis; Meta analysis; Polymorphism; TNFA

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CHRONIC GASTRITIS; CYTOKINE PRODUCTION; DNA POLYMORPHISM; DUODENUM ULCER; ETHNIC GROUP; ETHNICITY; GASTRITIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; META ANALYSIS; PEPTIC ULCER; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH ULCER;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVALUATION STUDIES AS TOPIC; GASTRITIS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898924266     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1206-0     Document Type: Article

References (68)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
3. Peek Jr RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28-37. (Pubitemid 37328805)
4. El Omar EM, Chow WH, Rabkin CS. Gastric cancer and H. pylori : host genetics open the way. Gastroenterology. 2001;121:1002-4. (Pubitemid 32959409)
5. Macarthur M, Hold GL, El Omar EM. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 2004;286:G515-20. (Pubitemid 38374969)
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735-40. (Pubitemid 23006271)
7. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72:1605-21. (Pubitemid 44666739)
8. Raabe T, Bukrinsky M, Currie RA. Relative contribution of transcription and translation to the induction of tumor necrosis factoralpha by lipopolysaccharide. J Biol Chem. 1998;273:974-80. (Pubitemid 28049193)
9. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factoralpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443-9. (Pubitemid 29374077)
10. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, et al. A polymorphismthat affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999;22:145-50. (Pubitemid 29264807)
11. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1:353.
12. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34:391-9. (Pubitemid 27368335)
13. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508-10.
14. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 1995;182:1259-64.
15. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol. 1999;30:237-41. (Pubitemid 29071186)
16. Li DW, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 2006;15:1995-2002. (Pubitemid 43983273)
17. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-29.
18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. (Pubitemid 37088507)
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
20. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693-708. (Pubitemid 29481404)
21. Egger M, Davey Smith G, Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. (Pubitemid 27387172)
22. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166:41-6. (Pubitemid 32274283)
23. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol. 2001;54:703-6. (Pubitemid 32835419)
24. Lanas A, García-González MA, Santolaria S, Crusius JB, Serrano MT, Benito R, et al. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun. 2001;2:415-21. (Pubitemid 33674260)
25. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 2003;125:364-71. (Pubitemid 36929416)
26. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193-201. (Pubitemid 36531795)
27. Lee SG, Kim B, Yook JH, Oh ST, Lee I, Song K. TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine. 2004;28:75-82. (Pubitemid 39295688)
28. Glas J, Török HP, Schneider A, Brünnler G, Kopp R, Albert ED, et al. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol. 2004;22:4746-52.
29. Fei BY, Xia B, Deng CS, Xia XQ, Xie M, Crusius JB, et al. Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population. World J Gastroenterol. 2004;10:1256-61. (Pubitemid 39162427)
30. Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M, et al. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine. 2005;30:293-302. (Pubitemid 40775849)
31. Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, Park JY, et al. Association of polymorphismof IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett. 2005;225:207-14.
32. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631-6. s. (Pubitemid 41214153)
33. Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol. 2005;100:290-4. (Pubitemid 40314511)
34. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141-52. (Pubitemid 40126232)
35. Rocha GA, Guerra JB, Rocha AM, Saraiva IE, da Silva DA, de Oliveira CA, et al. IL1RN polymorphic gene and cagA-positive status independently increase the risk of noncardia gastric carcinoma. Int J Cancer. 2005;115:678-83. (Pubitemid 40776689)
36. Garza-González E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina- Menchaca R, Maldonado-Garza HJ, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer. 2005;114:237-41. (Pubitemid 40194292)
37. Garcia-Gonzalez MA, Savelkoul PH, Benito R, Santolaria S, Crusius JB, Peña AS, et al. No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease. Int J Immunogenet. 2005;32:299-306. (Pubitemid 41392374)
38. Lu CC, Sheu BS, Chen TW, Yang HB, Hung KH, Kao AW, et al. Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection. Am J Gastroenterol. 2005;100:1274-82.
39. Morgan DR, Dominguez RL, Keku TO, Heidt PE, Martin CF, Galanko JA, et al. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol. 2006;4:1103-11. (Pubitemid 44311643)
40. Kim N, Cho SI, Yim JY, Kim JM, Lee DH, Park JH, et al. The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea. Helicobacter. 2006;11:105-12. (Pubitemid 43363309)
41. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117-25. (Pubitemid 43084810)
42. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis. 2007;28:118-23. (Pubitemid 44942634)
43. Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, Kajimura M, et al. Different effects of polymorphisms of tumor necrosis factoralpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol. 2007;22:51-9. (Pubitemid 44953416)
44. García-González MA, Lanas A, Quintero E, Nicolás D, Parra-Blanco A, Strunk M, et al. Gastric cancer susceptibility is not linked to proand anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol. 2007;102:1878-92. (Pubitemid 47301539)
45. Crusius JB, Canzian F, Capellá G, Peña AS, Pera G, Sala N, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894-902.
46. Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B. Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development. Dig Dis Sci. 2008;53:622-9. (Pubitemid 351317079)
47. Chakravorty M, De Datta D, Choudhury A, Santra A, Roychoudhury S. Association of specific haplotype of TNFalpha with Helicobacter pylori -mediated duodenal ulcer in eastern Indian population. J Genet. 2008;87:299-304.
48. Szoke D, Molnar B, Solymosi N, Klausz G,Gyulai Z, Toth B, et al. T-251A polymorphism of IL-8 relating to the development of histological gastritis and G-308A polymorphism of TNF-alpha relating to the development of macroscopic erosion. Eur J Gastroenterol Hepatol. 2008;20:191-5. (Pubitemid 351317356)
49. Murphy G, Thornton J, McManus R, Swan N, Ryan B, Hughes DJ, et al. Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol. 2009;21:630-5.
50. Xiao H, Li C, Jiang Y, Li R, Xia B. The relationship among IL-10. TNF gene polymorphisms, Helicobacter pylori infection and gastroduodenal diseases in Hubei Han ethnic. Zhonghua Nei Ke Za Zhi. 2009;48:552-6.
51. Barbosa HPM, Martins LC, dos Santos SEB, Demachki S, Assumpç ão MB, Aragão CD, et al. Interleukin-1 and TNF-α polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol. 2009;15:1465-71.
52. Yang JJ, Ko KP, Cho LY, Shin A, Gwack J, Chang SH, et al. The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case- control study. BMC Cancer. 2009;9:238.
53. Cheng HH, Chang CS, Wang HJ, Wang WC. Interleukin-1beta and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients. J Gastroenterol Hepatol. 2010;25:1443-51.
54. Shin CM, Kim N, Lee HS, Lee DH, Kim JS, Jung HC, et al. Intrafamilial aggregation of gastric cancer: a comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility. Eur J Gastroenterol Hepatol. 2011;23:411-7.
55. Santos JC, Ladeira MS, Pedrazzoli Jr J, Ribeiro ML. Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res. 2012;45:811-7.
56. Hong Y, Ge Z, Jing C, Shi J, Dong X, Zhou F, et al. Functional promoter -308G>Avariant in tumor necrosis factor α gene is associated with risk and progression of gastric cancer in a Chinese population. PLoS One. 2013;8:e50856.
57. de Oliveira JG, Rossi AF, Nizato DM, Miyasaki K, Silva AE. Profiles of gene polymorphisms in cytokines and Toll-like receptors with higher risk for gastric cancer. Dig Dis Sci. 2013;58:978-88.
58. Han F, Wang X, Wang X, Luo Y, Li W. Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking. Mol Biol Rep. 2012;39:8335-44.
59. 3 upregulated protein 1 deficiency promotes N -methyl-Nnitrosourea and Helicobacter pylori-induced gastric carcinogenesis in mice. Gut. 2012;61:53-63.
60. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
61. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27-38. (Pubitemid 43025390)
62. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680-7. (Pubitemid 35446836)
63. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells bymultiple pathways. Gut. 1998;42:227-34. (Pubitemid 28212178)
64. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994;29:425-9. (Pubitemid 24144511)
65. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411-52.
66. Neu B, Puschmann AJ, Mayerhofer A, Hutzler P, Grossmann J, Lippl F, et al. TNF-alpha induces apoptosis of parietal cells. Biochem Pharmacol. 2003;65:1755-60. (Pubitemid 36577289)
67. Abrahamsson J, Carlsson B, Mellander L. Tumor necrosis factoralpha inmalignant disease. J Pediatr Hematol Oncol. 1993;15:364-9.
68. Nakashima J, Tachibana M, Ueno M, Miyajima A, Baba S, Murai M. Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin Cancer Res. 1998;4:1743-8. (Pubitemid 28304737)